Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study
One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts...
Gespeichert in:
Veröffentlicht in: | Genitourinary Medicine 1986-10, Vol.62 (5), p.352-355 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 355 |
---|---|
container_issue | 5 |
container_start_page | 352 |
container_title | Genitourinary Medicine |
container_volume | 62 |
creator | Mohanty, K C Scott, C S |
description | One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts of a shorter duration. Supplementation of conventional treatment with inosine pranobex increased the success rate from 41% to 94%. Immunological studies in 134 patients with genital warts showed an increased number of B cells in 21% of peripheral blood samples. Absence of major defects among circulating lymphocytes suggested that patients with genital warts may have a local immune reaction. |
doi_str_mv | 10.1136/sti.62.5.352 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1011990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77103830</sourcerecordid><originalsourceid>FETCH-LOGICAL-b571t-55b95e0bee49e49da0dd4e87302a24d4ae312d08cb82f95a934ad8c27488061e3</originalsourceid><addsrcrecordid>eNqFkduLEzEYxYMoa62--SoMKF7AqblffBC0eOmyKCvqa8jMpNt0Z5KaZHa3_70pLUV9UAgEcn45nO87ADxEcIYQ4a9SdjOOZ2xGGL4FJogKXBPMyW0wgZjzmhIq74J7Ka0hhFwwdQJOMMVKQTkBXxfDMPqQVzaazbYKy-rCepdNX12bmFN17fKqcj4k5221icaHxt5Uzxe7T1cuvnhdHm3vBudN3FYpj932PrizNH2yDw73FHz_8P7b_FN99uXjYv72rG6YQLlmrFHMwsZaqsrpDOw6aqUgEBtMO2osQbiDsm0kXipmFKGmky0WVErIkSVT8GbvuxmbwXat9TmaXm-iG0oWHYzTfyrerfRFuNIIIlSmLwZPDwYx_BxtynpwqbV9b7wNY9JCIEgk-T9YVk645LiAj_8C12GMvmxBIyGgwkLgnd3LPdXGkFK0y2NmBPWuUl0q1RxrpkulBX_0-5xH-NBh0Z8cdJNa0y9LSa1LR0woqHhxnYJ6j7mU7c1RNvFSc0EE059_zPU5end6zk6RpoV_tuebYf3vgL8A-XPF7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770927720</pqid></control><display><type>article</type><title>Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Mohanty, K C ; Scott, C S</creator><creatorcontrib>Mohanty, K C ; Scott, C S</creatorcontrib><description>One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts of a shorter duration. Supplementation of conventional treatment with inosine pranobex increased the success rate from 41% to 94%. Immunological studies in 134 patients with genital warts showed an increased number of B cells in 21% of peripheral blood samples. Absence of major defects among circulating lymphocytes suggested that patients with genital warts may have a local immune reaction.</description><identifier>ISSN: 0266-4348</identifier><identifier>ISSN: 1368-4973</identifier><identifier>EISSN: 1472-3263</identifier><identifier>DOI: 10.1136/sti.62.5.352</identifier><identifier>PMID: 2429908</identifier><identifier>CODEN: GEMEE2</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>Adjuvants, Immunologic - therapeutic use ; Adult ; Biological and medical sciences ; Clinical Trials as Topic ; Female ; Genital Diseases, Female - therapy ; Genital Diseases, Male - therapy ; Humans ; Immunomodulators ; Inosine - analogs & derivatives ; Inosine Pranobex - therapeutic use ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Podophyllin - therapeutic use ; Prospective Studies ; Random Allocation ; Warts - therapy</subject><ispartof>Genitourinary Medicine, 1986-10, Vol.62 (5), p.352-355</ispartof><rights>1987 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Oct 1986</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b571t-55b95e0bee49e49da0dd4e87302a24d4ae312d08cb82f95a934ad8c27488061e3</citedby><cites>FETCH-LOGICAL-b571t-55b95e0bee49e49da0dd4e87302a24d4ae312d08cb82f95a934ad8c27488061e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1011990/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1011990/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7909611$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2429908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohanty, K C</creatorcontrib><creatorcontrib>Scott, C S</creatorcontrib><title>Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study</title><title>Genitourinary Medicine</title><addtitle>Genitourin Med</addtitle><description>One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts of a shorter duration. Supplementation of conventional treatment with inosine pranobex increased the success rate from 41% to 94%. Immunological studies in 134 patients with genital warts showed an increased number of B cells in 21% of peripheral blood samples. Absence of major defects among circulating lymphocytes suggested that patients with genital warts may have a local immune reaction.</description><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Female</subject><subject>Genital Diseases, Female - therapy</subject><subject>Genital Diseases, Male - therapy</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Inosine - analogs & derivatives</subject><subject>Inosine Pranobex - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Podophyllin - therapeutic use</subject><subject>Prospective Studies</subject><subject>Random Allocation</subject><subject>Warts - therapy</subject><issn>0266-4348</issn><issn>1368-4973</issn><issn>1472-3263</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkduLEzEYxYMoa62--SoMKF7AqblffBC0eOmyKCvqa8jMpNt0Z5KaZHa3_70pLUV9UAgEcn45nO87ADxEcIYQ4a9SdjOOZ2xGGL4FJogKXBPMyW0wgZjzmhIq74J7Ka0hhFwwdQJOMMVKQTkBXxfDMPqQVzaazbYKy-rCepdNX12bmFN17fKqcj4k5221icaHxt5Uzxe7T1cuvnhdHm3vBudN3FYpj932PrizNH2yDw73FHz_8P7b_FN99uXjYv72rG6YQLlmrFHMwsZaqsrpDOw6aqUgEBtMO2osQbiDsm0kXipmFKGmky0WVErIkSVT8GbvuxmbwXat9TmaXm-iG0oWHYzTfyrerfRFuNIIIlSmLwZPDwYx_BxtynpwqbV9b7wNY9JCIEgk-T9YVk645LiAj_8C12GMvmxBIyGgwkLgnd3LPdXGkFK0y2NmBPWuUl0q1RxrpkulBX_0-5xH-NBh0Z8cdJNa0y9LSa1LR0woqHhxnYJ6j7mU7c1RNvFSc0EE059_zPU5end6zk6RpoV_tuebYf3vgL8A-XPF7g</recordid><startdate>19861001</startdate><enddate>19861001</enddate><creator>Mohanty, K C</creator><creator>Scott, C S</creator><general>BMJ Publishing Group Ltd</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19861001</creationdate><title>Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study</title><author>Mohanty, K C ; Scott, C S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b571t-55b95e0bee49e49da0dd4e87302a24d4ae312d08cb82f95a934ad8c27488061e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Female</topic><topic>Genital Diseases, Female - therapy</topic><topic>Genital Diseases, Male - therapy</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Inosine - analogs & derivatives</topic><topic>Inosine Pranobex - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Podophyllin - therapeutic use</topic><topic>Prospective Studies</topic><topic>Random Allocation</topic><topic>Warts - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohanty, K C</creatorcontrib><creatorcontrib>Scott, C S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Genitourinary Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohanty, K C</au><au>Scott, C S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study</atitle><jtitle>Genitourinary Medicine</jtitle><addtitle>Genitourin Med</addtitle><date>1986-10-01</date><risdate>1986</risdate><volume>62</volume><issue>5</issue><spage>352</spage><epage>355</epage><pages>352-355</pages><issn>0266-4348</issn><issn>1368-4973</issn><eissn>1472-3263</eissn><coden>GEMEE2</coden><abstract>One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts of a shorter duration. Supplementation of conventional treatment with inosine pranobex increased the success rate from 41% to 94%. Immunological studies in 134 patients with genital warts showed an increased number of B cells in 21% of peripheral blood samples. Absence of major defects among circulating lymphocytes suggested that patients with genital warts may have a local immune reaction.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>2429908</pmid><doi>10.1136/sti.62.5.352</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0266-4348 |
ispartof | Genitourinary Medicine, 1986-10, Vol.62 (5), p.352-355 |
issn | 0266-4348 1368-4973 1472-3263 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1011990 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection |
subjects | Adjuvants, Immunologic - therapeutic use Adult Biological and medical sciences Clinical Trials as Topic Female Genital Diseases, Female - therapy Genital Diseases, Male - therapy Humans Immunomodulators Inosine - analogs & derivatives Inosine Pranobex - therapeutic use Male Medical sciences Pharmacology. Drug treatments Podophyllin - therapeutic use Prospective Studies Random Allocation Warts - therapy |
title | Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A10%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunotherapy%20of%20genital%20warts%20with%20inosine%20pranobex%20(Imunovir):%20preliminary%20study&rft.jtitle=Genitourinary%20Medicine&rft.au=Mohanty,%20K%20C&rft.date=1986-10-01&rft.volume=62&rft.issue=5&rft.spage=352&rft.epage=355&rft.pages=352-355&rft.issn=0266-4348&rft.eissn=1472-3263&rft.coden=GEMEE2&rft_id=info:doi/10.1136/sti.62.5.352&rft_dat=%3Cproquest_pubme%3E77103830%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770927720&rft_id=info:pmid/2429908&rfr_iscdi=true |